| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2651335 | Heart & Lung: The Journal of Acute and Critical Care | 2013 | 7 Pages |
Abstract
PTX3 was not superior to CRP as a biomarker to diagnose VAP, but it was an early indicator of inflammation and had better prognostic value to predict mortality than CRP.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Qionghua MD, Fengming MD, Lihua MD, Biao MD,